Four new myeloma drugs were approved by the US Food and Drug Administration last year. Understand what they are and how they can be used most effectively at the upcoming IMF Patient & Family Seminar in Philadelphia, Pennsylvania, April 8–9, 2016 at the Sheraton Philadelphia Downtown Hotel.
On Friday, myeloma experts will discuss with participants how to manage side effects, how to understand the FreeLite® and HevyLite® assays, and how to live well with myeloma.
On Saturday, breakout session topics will include: myeloma basics, best therapies for elderly patients, best therapies for patients opting for transplant, updates on the Black Swan Research Initiative, management of bone disease, clinical trials, and all the new drugs available in 2016.
If you are interested in this event: Register here